Evidence map›Paper›PMID 28096418›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks.

Gustavo C Cerqueira, Ashlee M Earl, Christoph M Ernst, Yonatan H Grad, John P Dekker, Michael Feldgarden, Sinéad B Chapman, João L Reis-Cunha, Terrance P Shea, Sarah Young and 16 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Differential virulence potential of different clades of multidrug-resistantmedRxiv : the preprint server for health sciences · 2026
    Article
  5. Genomic Epidemiology of ClinicalAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Molecular Insights into Carbapenem Resistance inInternational journal of molecular sciences · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Emerging carbapenem-resistantMicrobiology spectrum · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Deciphering the gastrointestinal carriage ofInfection and immunity · 2024
    Review
  18. Article
  19. An Intra-Hospital Spread of Colistin-ResistantMedicina (Kaunas, Lithuania) · 2024
    Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Gustavo C CerqueiraBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Ashlee M EarlBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Christoph M ErnstBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Yonatan H GradBroad Institute of MIT and Harvard, Cambridge, MA 02142.ORCID 0000-0001-5646-1314
John P DekkerMassachusetts General Hospital, Boston, MA 02114.
Michael FeldgardenBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Sinéad B ChapmanBroad Institute of MIT and Harvard, Cambridge, MA 02142.
João L Reis-CunhaBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Terrance P SheaBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Sarah YoungBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Qiandong ZengBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Mary L DelaneyInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais, CEP 31270, Belo Horizonte, Brazil.
Diane KimDivision of Infectious Diseases, School of Medicine, University of California, Irvine, CA 92617.
Ellena M PetersonDepartment of Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine, CA 92617.
Thomas F O'BrienInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais, CEP 31270, Belo Horizonte, Brazil.
Mary Jane FerraroMassachusetts General Hospital, Boston, MA 02114.
David C HooperMassachusetts General Hospital, Boston, MA 02114.
Susan S HuangDivision of Infectious Diseases, School of Medicine, University of California, Irvine, CA 92617.
James E KirbyBeth Israel Deaconess Medical Center, Boston, MA 02215.
Andrew B OnderdonkInstituto de Ciências Biológicas, Universidade Federal de Minas Gerais, CEP 31270, Belo Horizonte, Brazil.
Bruce W BirrenBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Deborah T HungBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Lisa A CosimiBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Jennifer R WortmanBroad Institute of MIT and Harvard, Cambridge, MA 02142.
Cheryl I MurphyBroad Institute of MIT and Harvard, Cambridge, MA 02142.
William P HanageCenter for Communicable Disease Dynamics, Harvard T. H. Chan School of Public Health, Boston, MA 02115; whanage@hsph.harvard.edu.

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI PARK, DANIEL JOHN · 2014 to 2024
$66.5M
Genomic epidemiology of Neisseria gonorrhoeae with elevated MICs to cefiximeK08AI104767 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI GRAD, YONATAN H · 2013 to 2015
$547k
VALIDATION OF A HIGH THROUGHPUT SCREEN FOR KPC PLASMID EVICTIONR21AI112694 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KIRBY, JAMES E · 2015 to 2016
$479k
Plasmid Eviction to Restore Susceptibility in Carbapenem-Resistant EnterobacteriaceaeR21AI119114 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KIRBY, JAMES E · 2015 to 2016
$305k
NIAID NIH HHS HHSN272200900018CNIAID NIH HHS K08 AI104767NIAID NIH HHS R21 AI112694NIAID NIH HHS R21 AI119114NIAID NIH HHS U19 AI110818
6 · The paper itself

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) are among the most severe threats to the antibiotic era. Multiple different species can exhibit resistance due to many different mechanisms, and many different mobile elements are capable of transferring resistance between lineages. We prospectively sampled CRE from hospitalized patients from three Boston-area hospitals, together with a collection of CRE from a single California hospital, to define the frequency and characteristics of outbreaks and determine whether there is evidence for transfer of strains within and between hospitals and the frequency with which resistance is transferred between lineages or species. We found eight species exhibiting resistance, with the majority of our sample being the sequence type 258 (ST258) lineage of Klebsiella pneumoniae There was very little evidence of extensive hospital outbreaks, but a great deal of variation in resistance mechanisms and the genomic backgrounds carrying these mechanisms. Local transmission was evident in clear phylogeographic structure between the samples from the two coasts. The most common resistance mechanisms were KPC (K. pneumoniae carbapenemases) beta-lactamases encoded by bla

Indexed as

Disease OutbreaksBacterial Proteinsbeta-Lactamasesbeta-Lactam ResistanceBostonCarbapenemsClone CellsCross InfectionDNA Transposable ElementsEnterobacteriaceaeEnterobacteriaceae InfectionsGenetic VariationGenome, BacterialHumansProspective StudiesR FactorsBacterial Proteinsbeta-LactamasesCarbapenemsDNA Transposable Elementscarbapenem resistancecomparative genomicsEnterobacteriaceaemolecular evolutionwhole-genome sequencing

Identifiers

PMID28096418
PMCPMC5293017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.